Inventure Capital (Denmark)

Inventure Capital (Denmark) Overview

Investor Type Venture Capital
Status Inactive
Investments 12
Portfolio 4
Exits 5
Exits

Inventure Capital (Denmark) General Information

Description

Inventure Capital A/S was an early stage venture capital firm that seeked to make investments in the information and communication technology, life sciences and clean technology sectors. The firm was headquartered in Denmark.

Contact Information

Year Founded
2006
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • Nørreport 26
  • 2
  • 8000 Aarhus
  • Denmark

Inventure Capital (Denmark) Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mirrx Therapeutics 04-Feb-2010 Seed Round Biotechnology Out of Business
0000 02-Mar-2009 00000 00000 00.000 Electronic Equipment and Instruments Generating Revenue
000000 000000 17-Jan-2008 00000 00000 0000 Drug Discovery Bankruptcy: Liquidation
00000000 21-Aug-2007 00000 00000 00.00 Application Software Startup
000000000000 01-Jan-2007 00000 00000 Entertainment Software Out of Business
000000 000000 27-Oct-2006 00000 00000 00.000 Drug Discovery Bankruptcy: Liquidation
000 0000000000000 30-Jun-2006 00000 00000 IT Consulting and Outsourcing Startup
00000 00000000 02-Jan-2006 00000 00000 Internet Service Providers Product Development
aCon 28-Dec-2005 Early Stage VC Electronic Equipment and Instruments Generating Revenue
Tpack 29-May-2002 Early Stage VC 00.000 Connectivity Products Generating Revenue
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventure Capital (Denmark) Exits (5)

To view Inventure Capital (Denmark)‘s complete exit history, request access >>
Company Name Exit Date Exit Type Exit Size
Mirrx Therapeutics 01-Dec-2016 Out of Business
000000000000 25-Sep-2015 0000000000: 000000
00000 21-Sep-2010 000000000000000000 000.00
Dansk Bredband 15-Jun-2010 Merger/Acquisition 000.00
Action Pharma Bankruptcy: Liquidation